Mr. Trevor Vieweg reports

MEDBRIGHT AI'S MEDMATRIX TO EXPAND ITS AI OFFERINGS FOR COSMETIC MARKETING & CLINICAL TRIAL ANALYTICS

Rejuvenation, a prominent dermatology group and a leader in advanced dermatological care, is expanding its use of Medbright AI Investments Inc.'s MedMatrix to include marketing for cosmetic treatments and clinical trial recruitment and data analysis.

Rejuvenation's extensive network includes eight clinics spread across three provinces in Canada. The group boasts a highly skilled team comprising 21 dermatologists, five Mohs surgeons, two plastic surgeons and 13 general practitioners specializing in dermatology. This expansion of MedMatrix to cosmetic marketing and clinical trial data analytics is set to further improve their leadership in these spaces. The cosmetic marketing product will help Rejuvenation identify the best candidates for cosmetic treatments and offer personalized recommendations to cosmetic patients, improving both patient experience and treatment outcome. The clinical trial recruitment tools will enable Rejuvenation to rapidly assess patient eligibility for clinical trials, improving patient access to new treatments and speeding up the process of clinical trial recruitment for Rejuvenation's partners.

"We are excited to expand our work with Rejuvenation to further improve their already impressive operations in cosmetic treatment marketing and clinical trials," said Trevor Vieweg, chief executive officer of Medbright AI. "Combining the power of MedMatrix with the large patient base of Rejuvenation is set to provide new opportunities for Rejuvenation and improve the patient experience for their customers."

About Medbright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in health care technology companies. The team at Medbright prides themselves on unparalleled access to opportunities, as well as structuring unique and advantageous investments.

We seek Safe Harbor.